A Study of Hypofractionated Radiotherapy for Limited Metastatic NSCLC Harboring Sensitizing EGFR Mutations After First Line TKI Therapy
Clinical trial NCT02788058 · UNKNOWN
Trial details
- NCT number
- NCT02788058
- Sponsor
- First People's Hospital of Hangzhou
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-01
- Primary completion
- 2021-05-01
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.